PerkinElmer Expands Leading Offering of New GPCR Cell Lines for Life Sciences and Drug Discovery Research
LILLE, France, Apr 28, 2009 (BUSINESS WIRE) --At the 15th Annual Society for Biomolecular Sciences (SBS) Conference , PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the release of 16 new G-protein coupled receptor (GPCR) and ion channel cell lines. With these latest offerings, PerkinElmer's GPCR cell lines portfolio is now increased to over 300.
The new cell line offering further expands the company's leading position in validated cell lines for use in researching diseases, including cancer, inflammation, metabolic and central nervous system disorders.
"PerkinElmer has long been a leader in providing life science researchers with an extensive offering in GPCR technologies, including validated cell lines, detection reagents, and instruments that provide the mainstay of most cell based screening assays. In addition, we also provide a set of recombinant cell lines for use in ion channel research," said Richard M. Eglen, PhD, president, Bio-discovery, PerkinElmer. "GPCRs are implicated in over one third of all known disease states, and are widely recognized to be proven drug discovery targets. These new GPCR and ion channel cell lines from PerkinElmer will provide customers with additional tools to generate novel therapeutic compounds in many areas of drug discovery."
PerkinElmer's latest GPCRs and ion channels cell lines release comprises:
| Family | Receptor Type |
|---|
| GPCRs | GPR | GPR120 |
|---|
| Protease Activated | PAR4 |
| Lysophospholipid | S1P2 (Edg5) |
| Urotensin | rUT |
| Serotonin | 5-HT3A |
| Glucagon | GLP-2 |
| Prokineticin | PKR2 |
| GPR | GPR91 |
| Glucagon | Secretin |
| Dopamine | D2L |
| Purinergic | P2Y11 |
| GPR | GPR1 |
| NeuropeptideFF | NPFF1 |
| Ion channels | Voltage gated potassium channel | Kv1.3 (KCNA3) |
|---|
| Transient receptor potential channel | TRPC3 cell line |
| Transient receptor potential channel | TRPC6 cell line |
For a complete listing of PerkinElmer's GPCR cell lines offering, please visit: www.perkinelmer.com/GPCR
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2 billion in 2008, has around 8,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.
SOURCE: PerkinElmer, Inc.
PerkinElmer, Inc.
Mario Fante
781-663-5602
mario.fante@perkinelmer.com
Copyright Business Wire 2009